Terms: = Colorectal cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Prognosis
24 results:
1. Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
Anijs RJS; Chen Q; van der Hulle T; Versteeg HH; Klok FA; Lijfering WM; Cannegieter SC
Thromb Res; 2023 Sep; 229():90-98. PubMed ID: 37421683
[TBL] [Abstract] [Full Text] [Related]
2. Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy.
Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Takata N; Tsuruoka S; Uwatsu K; Kido T
Med Sci (Basel); 2023 Feb; 11(1):. PubMed ID: 36810484
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive comparative analysis of prognostic value of serum systemic inflammation biomarkers for colorectal cancer: Results from a large multicenter collaboration.
Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Song M; Zhang X; Liu X; Lin S; Yang M; Hu C; Tang M; Deng L; Hu W; Shi H
Front Immunol; 2022; 13():1092498. PubMed ID: 36685502
[TBL] [Abstract] [Full Text] [Related]
4. Associations between serum vitamin D biomarkers and tumor expression of Ki67, p53, and COX-2 in colorectal cancer cases from the Southern Community Cohort Study.
Lawler T; Su T; Cai Q; Steinwandel MD; Zheng W; Blot WJ; Warren Andersen S
J Steroid Biochem Mol Biol; 2023 Jan; 225():106201. PubMed ID: 36210028
[TBL] [Abstract] [Full Text] [Related]
5. The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma.
Ye S; Zhou S; Zhong S; Shan B; Jiang W; Yang W; Cai X; Yang H
BMC Cancer; 2022 Apr; 22(1):449. PubMed ID: 35461222
[TBL] [Abstract] [Full Text] [Related]
6. Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study.
Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
Radiat Oncol; 2021 Nov; 16(1):225. PubMed ID: 34801042
[TBL] [Abstract] [Full Text] [Related]
7. Serum C-Reactive Protein-to-Body Mass Index Ratio Predicts Overall Survival in Patients With Resected colorectal cancer.
Huang L; Liu J; Huang X; Wei C; Mo X; Zhong H; Meng Y; Lai H; Zhang L; Liang D; Liu H; Tang W
Technol Cancer Res Treat; 2021; 20():15330338211037418. PubMed ID: 34338056
[TBL] [Abstract] [Full Text] [Related]
8. Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trial.
Hansdotter P; Scherman P; Petersen SH; Mikalonis M; Holmberg E; Rizell M; Naredi P; Syk I
BJS Open; 2021 Jul; 5(4):. PubMed ID: 34308474
[TBL] [Abstract] [Full Text] [Related]
9. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
[TBL] [Abstract] [Full Text] [Related]
10. colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS).
Baratti D; Kusamura S; Azmi N; Guaglio M; Montenovo M; Deraco M
Ann Surg Oncol; 2020 Jan; 27(1):98-106. PubMed ID: 31691116
[TBL] [Abstract] [Full Text] [Related]
11. Does postoperative morphine consumption for acute surgical pain impact oncologic outcomes after colorectal cancer resection?: A retrospective cohort study.
Wu HL; Tai YH; Chang WK; Chang KY; Tsou MY; Cherng YG; Lin SP
Medicine (Baltimore); 2019 May; 98(18):e15442. PubMed ID: 31045812
[TBL] [Abstract] [Full Text] [Related]
12. Association between density of tumor-infiltrating lymphocytes and prognoses of patients with gastric cancer.
Yu PC; Long D; Liao CC; Zhang S
Medicine (Baltimore); 2018 Jul; 97(27):e11387. PubMed ID: 29979429
[TBL] [Abstract] [Full Text] [Related]
13. Impact of long-term antihypertensive and antidiabetic medications on the prognosis of post-surgical colorectal cancer: the Fujian prospective investigation of cancer (FIESTA) study.
Peng F; Hu D; Lin X; Liang B; Chen Y; Zhang H; Xia Y; Lin J; Zheng X; Niu W
Aging (Albany NY); 2018 May; 10(5):1166-1181. PubMed ID: 29846174
[TBL] [Abstract] [Full Text] [Related]
14. Promoter Methylation of RASSF1A indicates prognosis for Patients with Stage II and III colorectal cancer Treated with Oxaliplatin-Based Chemotherapy.
Sun X; Yuan W; Hao F; Zhuang W
Med Sci Monit; 2017 Nov; 23():5389-5395. PubMed ID: 29128865
[TBL] [Abstract] [Full Text] [Related]
15. The impact of chemotherapy-associated hemoglobin on prognosis of colorectal cancer patients receiving adjuvant chemotherapy.
Wei YS; Zhou YG; Wang GY; Liang ZH; Luo MR; Yang TA; Huang J
Cancer Biomark; 2017 Dec; 20(4):627-635. PubMed ID: 28800321
[TBL] [Abstract] [Full Text] [Related]
16. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
[No Abstract] [Full Text] [Related]
17. Is neoadjuvant chemoradiotherapy always necessary for mid/high local advanced rectal cancer: A comparative analysis after propensity score matching.
Zhang Y; Sun Y; Xu Z; Chi P; Lu X
Eur J Surg Oncol; 2017 Aug; 43(8):1440-1446. PubMed ID: 28502421
[TBL] [Abstract] [Full Text] [Related]
18. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
[TBL] [Abstract] [Full Text] [Related]
19. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for colorectal cancer: Models for Global and Disease-Free Survival.
Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D
PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab.
Price TJ; Hardingham JE; Lee CK; Townsend AR; Wrin JW; Wilson K; Weickhardt A; Simes RJ; Murone C; Tebbutt NC
Cancer Med; 2013 Jun; 2(3):277-85. PubMed ID: 23930204
[TBL] [Abstract] [Full Text] [Related]
[Next]
